Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC
| Autor: | Melosky, Barb, Sheffield, Brandon S., Tsou, Mei-Hua, Gagne, S. Eric, Ionescu (Naus), Diana N., Yang, James Chih-Hsin |
|---|---|
| Zdroj: | In Cancer Treatment and Research Communications 2017 11:10-16 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect